Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

12112studies shown

Showing 6,373-6,384 of 12,112

Drug study icon

CompletedNCT02504151

Cannabidiol Treatment in people with Early Psychosis

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including New Haven

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02069366

Cannabinoid Control of Fear Extinction Neural Circuits in PTSD

This study is completed. It focuses on PTSD and currently lists study information in the United States.

In Detroit

PTSDBehavioralFrom 21 Years to 45 Years

Countries: United States
Sponsor: Wayne State University
Condition: PTSD

Other study type icon

CompletedNCT01853020

Cannabinoids and Cerebellar-Motor Functioning

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

In West Haven

SchizophreniaOtherFrom 21 Years to 35 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT05041647

Cannabinoids as a Treatment for Insomnia in Major Depression

This study is completed. It focuses on depression and currently lists study information in Canada.

In Hamilton

DepressionDrugOver 19 Years

Countries: Canada
Sponsor: St. Joseph's Healthcare Hamilton
Condition: Depression

Other study type icon

WithdrawnNCT00397605

Cannabinoids in Bipolarity

This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.

In Vancouver

BipolarityOtherFrom 19 Years to 60 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Bipolarity

Other study type icon

Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in the United States.

In West Haven

SchizophreniaOtherFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Other study type icon

CompletedNCT00708994

Cannabinoids, Neural Synchrony, and Information Processing

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

In West Haven

SchizophreniaOtherFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Other study type icon

TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

This study has public registry information. It focuses on schizophrenia and currently lists study information in France.

In Bron

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: France
Sponsor: Hôpital le Vinatier
Condition: Schizophrenia

Drug study icon

Enrolling By InvitationNCT07222306

Cannabis, Neuroinflammation, and Suicide prevention: A Supplemental Brain Imaging Study

This study is enrolling by invitation. It focuses on suicide prevention and currently lists participation information in the United States.

In Detroit

Suicidality, PTSD, ...DrugFrom 19 Years to 69 Years

Countries: United States
Sponsor: Wayne State University
Condition: Suicidality, PTSD, ...

Drug study icon

CompletedNCT01964404

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including Lebanon

Schizophrenia, AddictionOtherFrom 18 Years to 55 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT02655692

CAP-Ketamine for Antidepressant Resistant PTSD

This study is completed. It focuses on PTSD and currently lists study information in the United States.

Multiple locations, including West Haven

PTSDDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Drug study icon

CompletedNCT02500602

CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

This study is completed. It focuses on PTSD and currently lists study information in the United States.

In Charleston

PTSDDrug

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.